The effect of polycystic ovary syndrome on health-related quality of life

References

• Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853–61
   PubMed Web of Science ®Google Scholar
• Scarpitta AM, Sinagra D. Polycystic ovary syndrome: an endocrine and metabolic disease. Gynecol Endocrinol 2000;14:392–5
   PubMed Web of Science ®Google Scholar
• Adams J, Franks S, Poison DW, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985;2:1375–9
   PubMed Web of Science ®Google Scholar
• Poison DW, Adams J, Wadsworth J, et al. Polycystic ovaries — a common finding in normal women. Lancet 1998;1:870–2
   Google Scholar
• Clayton RN, Ogden V, Hodgkinson J, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 1992;37: 127–34
   PubMed Web of Science ®Google Scholar
• Farquhar CM, Birdsall M, Manning P, et al. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust NZ J Obstet Gynaecol 1994;34:67–72
   PubMed Web of Science ®Google Scholar
• Michelmore KF, Balen AH, Dunger DB, et al. Polycystic ovaries and associated clinical and bio-chemical features in young women. Clin Endocrinol 1999;51:779–86
   PubMed Web of Science ®Google Scholar
• Rodin DA, Bano G, Bland JM, etal. Polycystic ovaries and associated abnormalities in Indian subcontinent Asian women. Clin Endocrinol 1998;49:91–9
   PubMed Web of Science ®Google Scholar
• Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol 1989;31:87–120
   PubMed Web of Science ®Google Scholar
• Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 1989;30: 459–70
   Google Scholar
• Balen AH, Conway GS, Kaltsas G, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107–11
   PubMed Web of Science ®Google Scholar
• Eden JA, Warren P. A review of 1019 consecutive cases of polycystic ovary syndrome demonstrated by ultrasound. Aust Radiol 1999;42:41–6
   Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for patho-genesis. Endo Rev 1997;18:774–800
   PubMed Web of Science ®Google Scholar
• Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the south-eastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–82
   Google Scholar
• Diamanti-Kandarakis E, Kouli CR, Bergiele AT, etal. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006–11
   PubMed Web of Science ®Google Scholar
• Asuncion M, Calvo RM, San Milan JL, et al. A prospective study of the prevalence of poly-cystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85:2434–8
   PubMed Web of Science ®Google Scholar
• Cronin L, Guyatt G, Griffith L, etal. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 1998; 83:1976–87
   PubMed Web of Science ®Google Scholar
• Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996;334:835–40
   PubMed Web of Science ®Google Scholar
• Muldoon MF, Barger SD, Flory JD, et al. What are quality of life measurements measuring? Br Med J 1998;316:542–5
   PubMed Web of Science ®Google Scholar
• Carr AJ, Gibson B, Robinson PG. Is quality of life determined by expectations or experience? Br Med J 2001;322:1240–3
   Google Scholar
• Bland JM, Altman DG. Validating scales and indexes. Br Med J 2002;324:606–7
   PubMedGoogle Scholar
• Jenkinson C, Layte R, Wright L, etal. The UK SF-36: an Analysis and Interpretation Manual. Oxford: Health Services Research Unit, 1996
   Google Scholar
• Bowling A. Measuring Disease: A Review of Disease-specific Quality of Life Measurement Scales. Buckingham: Open University Press, 1995:15
   Google Scholar
• Ware JE Jr, Sherboume C D. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30:473–83
   Google Scholar
• McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247–63
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr, Lu JFR, etal. The MOS 36-Item Short-Form Health Survey (SF-36): III Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40–66
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Coulter A, Wright, L. Short Form 36 (SF 36) health survey questionnaire: normative data for adults ofworking age. Br MedJ1993;306:1437–40
   PubMed Web of Science ®Google Scholar
• Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic condi-tions. J Am Med Assoc 1989;262:907–13
   PubMed Web of Science ®Google Scholar
• Trent ME, Rich M, Austin SB, et al. Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med 2002;156:556–60
   PubMedGoogle Scholar
• Trent ME, Rich M, Austin SB, etal. Fertility concerns and sexual behavious in adolescent girls with poly-cystic ovary syndrome: implications for quality of life. J Pediatr Adolesc Gynecol 2003;16:33–7
   PubMedGoogle Scholar
• Wong E, Cronin L, Griffith L, et al. Problems of HRQL assessment: how much is too much? J Clin Epidemiol 2001;54:1081–5
   PubMedGoogle Scholar
• Kitzinger C, Willmott J. 'The thief of womanhood': women's experience of polycystic ovarian syndrome. Soc Sci Med 2002;54:349–61
   PubMed Web of Science ®Google Scholar
• Orenstein H, Raskind MA, Wyllie D, et al. Poly-symptomatic complaints and Briquet's syndrome in poly-cystic ovary disease. Am J Psychiatry 1986;143:768–71
   PubMed Web of Science ®Google Scholar
• World Health Organization. International Statistical Classification of Diseases and Related Health Problems, rev 10. Geneva: World Health Organization, 1992
   Google Scholar
• Sadock BJ, Sadock VA. Comprehensive Textbook of Psychiatry. Philadelphia: Lippincott Williams & Wilkins, 2000:1515
   Google Scholar
• Modell E, Goldstein D, Reyes F I. Endocrine and behavioural responses to psychological stress in hyperandrogenic women. Fertil Steril 1990;53:454–9
   Google Scholar
• Gallinelli A, Matteo ML, Volpe A, et al. Autonomic and neuroendocrine response to stress in patients with functional hypothalamic secondary amenorrhea. Fertil Steril 2000;73:812–16
   PubMed Web of Science ®Google Scholar
• Dahan MH, Nguyen SL, Abu II, et al. Social implica-tions of Polycystic Ovary Syndrome (PCOS). 84th Meeting of the Endocrine Society, San Francisco, 19–22 June 2002:466
   Google Scholar
• Goldzieher JW, Green JA. The polycystic ovary. 1. Clinical and histological features. J Clin Endocrinol Metab 1962:22:325–38
   PubMed Web of Science ®Google Scholar
• O'Driscoll J, Mamtora H, Higginson J, et al. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol 1994;41:231–6
   PubMed Web of Science ®Google Scholar
• Barth JH, Catalan J, Cherry CA, et al. Psychological morbidity in women referred for treatment of hirsutism. J Psychosom Res 1993;37:615–19
   PubMed Web of Science ®Google Scholar
• Sonino N, Fava GA, Mani E, et al. Quality of life of hirsute women. Postgrad Med J 1993;69:186–9
   PubMed Web of Science ®Google Scholar
• Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. BrJ Dermatol 1999;140:672–6
   PubMed Web of Science ®Google Scholar
• Loo WJ, Lanigan SW. Laser treatment improves quality of life in hirsute females. Clin Exp Dermatol 2002;27:439–41
   Google Scholar
• Bunker CB, Newton JA Kilborn J, etal. Most women with acne have polycystic ovaries. Br J Dermatol 1989;121:675–80
   PubMedGoogle Scholar
• Betti R, Bencini P, Lodi A, etal. Incidence ofpolycystic ovaries in patients with late-onset or persistent acne: hormonal reports. Dermatologica 1990; 181:109–11
   PubMedGoogle Scholar
• Cibula D, Hill M, Vohradnikova O, et al. The role of androgens in determining acne severity in adult women. Br J Dermatol 2000;143:399–404
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846–50
   PubMed Web of Science ®Google Scholar
• Picardi A, Abeni D, Melchi CF, et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000;143:983–91
   PubMed Web of Science ®Google Scholar
• Klassen AF, Newton HN, Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol 2000;43:229–33
   Google Scholar
• Mulder MM, Sigurdsson V, van Zuuren EJ, et al. Psychosocial impact of acne vulgaris. Evaluation of the relation between a change in clinical acne severity and psychosocial state. Dermatology 2001; 203:124–30
   Google Scholar
• Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998;134:454–8
   PubMed Web of Science ®Google Scholar
• Martin AR, Lookingbill DP, Botek A, et al. Health-related quality of life among patients with facial acne — assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001;26:380–5
   PubMed Web of Science ®Google Scholar
• Dahlgren E, Johansson S, Lindstedt G, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 65: a long term follow up focusing on natural history and circulating hormones. Fertil Steril 1992;57:505–13
   PubMed Web of Science ®Google Scholar
• Legro RS, Kunselman AR, Dodson WC, et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in poly-cystic ovary syndrome: a prospective controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165–9
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Barnes RB, Rosenfield RL, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141–6
   PubMed Web of Science ®Google Scholar
• Pierpoint T, McKeigue PM, Isaacs AJ, et al. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998;51:581–6
   PubMed Web of Science ®Google Scholar
• Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol 2000;52: 81–6
   Google Scholar
• Peppard HR, Marfori J, Iuorno MJ, et al. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care 2001; 24:1050–2
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999;15:205–18
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999;22: 1125–36
   Google Scholar
• Strollo PJ Jr, Rogers RM. Obstructive sleep apnea. N Engl J Med 1996;334:99–104
   Google Scholar
• Fogel RB, Malhotra A, Pillar G, et al. Increased prevalence of obstructive sleep apea in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:1175–80
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Legro RS, Bhder EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001;86:517–20
   PubMed Web of Science ®Google Scholar
• Harding SM. Complications and consequences of obstructive sleep apnea. Curr Opin Pulmonary Med 2000;6:485–9
   Google Scholar
• Jenkinson C, Stradling J, Petersen S. Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea. J Sleep Res 1997;6:199–204
   Google Scholar
• D'Ambrosio C, Bowman T, Mohsenin V. Quality of life in patients with obstructive sleep apnea. Chest 1999;115:123–9
   PubMed Web of Science ®Google Scholar
• Bennett LS, Barbour C, Langford B, et al. Health status in obstructive sleep apnea. Am J Respir Crit Care Med 1999;159:1884–90
   Google Scholar
• Jenkinson C, Davies RJO, Mullins R, et al. Com-parison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100–5
   PubMed Web of Science ®Google Scholar
• Ballester E, Badia JR, Lourdes H, et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159: 495–501
   PubMed Web of Science ®Google Scholar
• Engleman HM, Kingshott RN, Wraith PK, et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:461–7
   PubMed Web of Science ®Google Scholar
• Schmidt 14, Garratt AM, Fitzpatrick R. Child/ parent-assessed population health outcome measures: a structured review. Child Care Health Dev 2002; 28: 227–37
   Google Scholar